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Abstract 
This study describes the bronchodilatory, vaso-relaxant and cardiac inhibitory 
effects of aqueous fractions of Olea europea (Oe.Aq) and Terminalia bellerica (Tb.Aq) 
fruits. In guinea-pig tracheal preparations, Oe.Aq and Tb.Aq caused concentration-
dependent (0.03-5 mg/mL) relaxation of carbachol (CCh, 1 µM) and high potassium (80 
mM)-induced contractions. When tested on rabbit aortic rings, against phenylephrine (PE, 1 
µM) and potassium (K+)-induced contractions, Oe.Aq and Tb.Aq caused non-specific 
inhibition of the induced contractions. In isolated guinea-pig atria, Oe.Aq and Tb.Aq 
exhibited a suppressive effect on the atrial force and the rate of contractions. These data 
indicate that Olea europea and Terminalia bellerica aqueous fractions possess airways and 
cardiovascular inhibitory activities, via calcium antagonism like verapamil.   
Rezumat 
Studiul experimental prezintă efectul bronhodilatator, vasorelaxant şi inhibitor 
cardiac al extractelor apoase obţinute din fructele speciilor Olea europea şi Terminalia bellerica. 
Rezultatele obţinute au demonstrat acţiunea bronhodilatatoare şi inhibitorie la 
nivel cardiovascular, printr-un mecanism ce presupune antagonismul cu ionii de calciu, 
similar verapamilului. 
Keywords: Olea europea; Terminalia bellerica; bronchodilator; 
vasodilatation; cardiac inhibitory effect 
 
Introduction       
   Olea europea (olive) is a small-growing evergreen tree native in the 
southern Europe and Asia Minor. The plant has a folkloric reputation as an 
aphrodisiac, emollient, laxative, nutritive, resolvent, sedative, tonic and is 
also considered useful to treat abdominal spasm [9] and hypertension [10]. 
Terminalia bellerica Roxb. (Combretaceae) commonly known as “belleric 
myrobalan” is a large deciduous tree, found throughout Central Asia and 
some other parts of the world [6]. Its fruit is used in folk medicine to treat 
anemia, asthma, cancer, spasm, cough, diarrhea, dyspepsia, dysuria, 
headache, hypertension, inflammations and rheumatism [1].  
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Materials and methods 
Chemicals and animals 
Acetylcholine chloride, carbachol (CCh), isoprenaline hydrochloride, 
phenylephrine hydrochloride (PE), potassium chloride and verapamil were 
purchased from Sigma Chemicals Co, St Louis, MO, USA. The animals used 
in this study were thirteen adult rabbits (1-1.5 kg) and twelve guinea-pigs (450-
500 g) of either sex and were housed at Animal House of Aga Khan University. 
Experiments performed complied with the rules of the Institute of Laboratory 
Animal Resources, Commission on Life Sciences, National Research Council 
[8] and were approved by the Ethical Committee of Aga Khan University.  
Preparation of plant aqueous fractions 
The Olea europea and Terminalia bellerica fruits were sliced and 
soaked individually in 70% aqueous-methanol solution. The initial preparation 
was filtered through a muslin cloth, then through Whatman filter paper. This 
procedure was repeated twice and the combined filtrate was evaporated using a 
rotary evaporator under reduced pressure. About 15 g of Olea europea and 10 g 
of Terminalia bellerica hydro-methanolic material were individually dissolved 
in about 200 mL of distilled water and after the treatment with different organic 
solvents: petroleum spirit, chloroform and ethyl acetate (separation performed 
using the separating funnel), the final lower layer was concentrated to obtain 
the aqueous fractions of Olea europea (Oe.Aq) and Terminalia bellerica 
(Tb.Aq), yielding 73.3% and 61.5% respectively.    
 Guinea-pig trachea       
 Nine guinea-pig tracheas obtained from animals, sacrificed by 
cervical dislocation, were dissected and kept in Krebs solution [4]. The 
preparation was then mounted in 20 mL tissue baths containing Kreb’s 
solution, maintained at 37º C and aerated with carbogen. A tension of 1 g 
was applied to each of the tracheal strip and was kept constant throughout 
the experiment. Changes in isometric tensions of strips were measured via 
force-displacement transducer (FT-03) using Grass model 7 Polygraph 
(Grass Instrument Company, Quincy, MA, USA).    
 Rabbit aorta        
 Thirteen thoracic aortas from rabbits, killed by blow on back of the 
head were isolated. Aortic rings of 2-3 mm width were mounted in 20 mL 
tissue baths containing Krebs solution, at 37ºC aerated with carbogen. A 
resting tension of 2 g was applied to each tissue [7]. The changes in 
isometric tensions of rings were measured using Grass model 7 Polygraph. 
 Guinea-pig atria 
Twelve right atrias isolated from guinea-pigs were mounted in 20 
mL tissue baths containing Krebs solution, at 32ºC and supplied carbogen 
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[4]. Tissues were allowed to beat spontaneously (due to the presence of 
pacemaker cells) under the resting tension of 1 g. Tension changes were 
recorded using the Grass model 7 Polygraph. 
Statistical analysis 
Data are expressed as mean ± standard error of mean (SEM, 
n=number of determinations) and the median effective concentrations 
(EC50) with 95% confidence intervals (CI).  
Results and discussion  
In tracheal preparations, Oe.Aq, Tb.Aq, and verapamil caused 
concentration-dependent inhibition of the CCh (1 µM) and potassium (K+, 80 
mM)-induced contractions with respective EC50 values of 2.2 mg/mL (1.1-4.8 
mg/mL, 95% CI, n=3) and 2.1 mg/mL (1.02-4.2 mg/mL, n=3), 3.16 mg/mL 
(3.1-3.3 mg/mL, n=3) and 3.21 mg/mL (1.9-5.5 mg/mL, n=3), 0.26 µM (0.17-
0.33 µM, n=3) and 0.05 µM (0.03-0.06 µM, n=3) as shown in Figure 1. Oe.Aq, 
Tb.Aq, and verapamil caused the relaxation of phenylephrine (PE, 1 µM) and 
K+ (80 mM)-induced contractions of aortic rings with EC50 values of 1.6 
mg/mL (1.0-2.7 mg/mL, n=5) and 1.7 mg/mL (1.0-2.9 mg/mL, n=5), 1.4 
mg/mL (0.84-2.3 mg/mL, n=3) and 1.7 mg/mL (1.0-2.9 mg/mL, n=3), 1.42 µM 
(1.0-2.0 µM, n=5) and 1.0 µM (0.80-1.3 µM, n=5) respectively (Figure 2). 
Oe.Aq, Tb.Aq, and verapamil caused concentration-dependent suppression of 
the force and rate of atrial spontaneous contractions, with EC50 values of 1.8 
mg/mL (1.0-3.1 mg/mL, n=4) and 1.4 mg/mL (0.81-2.4 mg/mL, n=4), 2.6 
mg/mL (1.4-3.0 mg/mL, n=4) and 3.3 mg/mL (2.1-4.9 mg/mL, n=4), 0.90 µM 
(0.70-1.2 µM, n=4) and 1.1 µM (0.82-1.6 µM, n=3) respectively (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
Concentration-dependent inhibitory effect of (A) Olea europea aqueous fraction (Oe.Aq), 
(B) Terminalia bellerica aqueous fraction (Tb.Aq) and (C) verapamil on the carbachol 
(CCh) and high K+ induced contractions of isolated guinea-pig tracheal preparations. 
Values shown are mean ± SEM, n=3. 
0.01 0.1 1
0
25
50
75
100
CCh (1 µM)
K+ (80 mM)
A
[Oe.Aq] mg/mL
In
hi
bi
tio
n 
of
 in
du
ce
d 
co
nt
ra
ct
io
n 
(%
)
0.03 0.3 3
0
25
50
75
100
K+ (80 mM)
CCh (1 µM)
B
[Tb.Aq] mg/mL
In
hi
bi
tio
n 
of
 in
du
ce
d 
co
nt
ra
ct
io
n 
(%
)
0.003 0.03 0.3
0
25
50
75
100
K+ (80 mM)
CCh (1 µM)
C
[Verapamil] µM
In
hi
bi
tio
n 
of
 in
du
ce
d 
co
nt
ra
ct
io
n 
(%
)
FARMACIA, 2010, Vol. 58, 6 
 
761 
 
 
 
 
 
          
 
 
 
 
 
 
Figure 2 
Inhibitory effect of (A) Olea europea aqueous fraction (Oe.Aq), (B) Terminalia bellerica 
aqueous fraction (Tb.Aq) and (C) verapamil on phenylephrine (PE) and high K+ induced 
contractions of isolated rabbit aortic preparations. Values shown are mean ± SEM, n=3-5 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
Concentration-dependent inhibitory effect of (A) Olea europea aqueous fraction (Oe.Aq), 
(B) Terminalia bellerica aqueous fraction (Tb.Aq) and (C) verapamil on the force and rate 
of isolated guinea-pig right atrial preparations. Values shown are mean ± SEM, n=3-4 
 
When tested on guinea-pig trachea, the Olea europea and 
Terminalia bellerica aqueous fractions relaxed both the CCh and high K+-
induced contractions, like verapamil, a standard Ca++ antagonist [3]. High 
levels of K+ (> 30 mM) and CCh, a cholinergic agonist, are known to cause 
smooth muscle contractions through opening voltage-dependent Ca++ 
channels and stimulation of muscarinic receptors respectively, eventually 
leading to increased intracellular Ca++ levels [4], resulting in a 
bronchoconstrictor effect. Inhibitory effects of the vegetal extracts against 
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the two spasmogens, indicate their non-specific bronchodilatory action, as 
exhibited by verapamil.       
Oe.Aq and Tb.Aq were studied further for the possible vaso-
relaxant and cardio-suppressant effects. In rabbit aortic rings, both plant 
fractions caused an inhibition of the PE and high K+-induced contractions, 
similar to that observed in the case of verapamil. PE produces vascular 
contraction through an increase in cytosolic Ca++, partly due to Ca++ influx 
via receptor operated channels and partly via Ca++ release from intracellular 
stores [5]. The inhibition of both PE and K+-induced contractions by Oe.Aq 
and Tb.Aq reveals their vasodilatory effect, via Ca++ antagonist pathway. 
When tested in spontaneously beating guinea-pig atria, Oe.Aq and 
Tb.Aq exhibited negative inotropic and chronotropic effects, similar to that 
caused by verapamil. The Ca++ antagonists are known to cause cardiac 
depression through inhibiting the slow inward current during the action 
potential plateau, leading to a decrease in the cardiac output [2] and thus 
falling blood pressure.      
 
Conclusions 
These results clearly indicate that Olea europea and Terminalia 
bellerica aqueous fractions possess bronchodilator and cardiovascular 
inhibitory effects, through a Ca++ antagonistic mechanism and thus provide 
an evidence for the therapeutic potential of both plants in respiratory and 
cardiovascular disorders. 
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